Clinical Trial Update: Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for mitoxantrone with granulocyte colony-stimulating factor in metastatic prostate cancer, covering Phase 1 and Phase 2; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Granulocyte Colony-Stimulating Factor (G-CSF) (G-CSF)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Hope Cancer Institute, Inc. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN